Eindhoven University of Technology (TU/e)
Eindhoven, The Netherlands
The Department of Biomedical Engineering (BME) of the Eindhoven University of Technology (TUE) in the Netherlands is a young department (~10 years) that has a strong focus on combining the fields of Engineering, Biology and Chemistry. TUE is one of the top level institutes of technology in Europe and number 1 world-wide in public-private co-authored publications.
University of Leeds (UoL)
Leeds, United Kingdom
The University of Leeds (UoL) is in the top 15 universities for research in the UK with some 3,000 researchers and annual research income of over €123m. UoL is a leading UK centre for life sciences research with strengths in chemical biology, biophysics, cell biology and structural molecular biology through the Astbury Centre for Structural Molecular Biology (ACSMB). ACSMB rings together 65 independent PIs with a shared grant portfolio of £60M and promotes collaborative multidisciplinary research and training involving chemists, biologists, physicists and other disciplines at the life sciences interface.
Charles University in Prague (CUNI)
Prague, Czech Republic
The Department of Physical and Macromolecular Chemistry at Faculty of Science ensures five master-degree programs and three doctoral programs from Physical Chemistry, Macromolecular Chemistry, Biophysical Chemistry, and related disciplines. Department offers variety of interesting subjects for master and doctoral theses in the fields of quantum chemistry, spectroscopy, statistical thermodynamics, computer simulations, reaction kinetics and catalysis, biophysical and colloidal chemistry, or physical chemistry of polymers.
University of Dundee (UoD)
Dundee, United Kingdom
The MacKintosh group is located in the Division of Cell and Developmental Biology, within the College of Life Sciences, University of Dundee. The 86 research groups of Dundee Life Sciences have the highest citations per paper in Biological Sciences outside of the US, and provides an exceptional collegiate environment, richness of expertise, industrial collaborations, and outstanding shared services and technology platforms, including microscopy, quantitative proteomics, structural analyses, bioinformatics, small molecule translational research and phenotypic assays.
University of Lille Nord de France
The University of Lille Nord de France (French: Université Lille Nord de France) is a center for higher education, academic research and doctoral studies located over multiple campuses centred in Lille, France. It includes a doctoral college that federates university institutes, engineering schools and research centres.
University of Siena (UniSi)
The Department of Biotechnology, Chemistry and Pharmacy (DBCF) of the University of Siena (SIE) brings together researchers from biotechnologies and molecular sciences, including expertise in bio-chemistry, molecular biology, chemistry and pharmaceutical chemistry and technology. The Department coordinates undergraduate and graduate degrees in the Chemical Sciences, in Pharmacy as well as in Chemistry and Pharmaceutical Technologies. The Department has an active PhD Program in Chemical and Pharmaceutical Sciences as well as in Molecular Biotechnologies. The Department also offers Masters degrees and a Specialization Course in Hospital Pharmacy.
Lead Discovery Center GmbH
LDC is a translational research center founded as spin-out of Max-Planck Innovation GmbH, having around 50 employees. LDC is an expert in the early drug discovery and generation of small molecule lead series by transferring projects of academic partners into commercially relevant assets. LDC is highly experienced in adapting projects from the public sector to application. LDC ́s cutting-edge expertise is in medicinal chemistry, (cellular) biology, pharmacology, assay development and screening. The LDC project managers with many years of experience from the biopharmaceutical industry ensure that the quality of results and products complies with international standards, and that partnerships are managed in a professional manner.
Taros Chemicals GmbH & Co. KG is a leading European chemistry-based SME located in Dortmund, Germany. Operational since its inception in 1999, it has steadily grown from a 3 people enterprise to its current size of 50 employees. Taros is a scientific contract research organization specialized in synthetic, medicinal and computational chemistry solutions and services to a large range of customers (eg. from material science industries to pharmaceutical companies, from academic units to the agrochemical sector, from philanthropist organizations to fine chemicals suppliers).
AstraZeneca is a global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare. Agnostic of source and modality AstraZeneca is committed to collaborate with the best scientists in the world to make a difference to patient health.
UCB Biopharma SPRL
UCB is a global biopharmaceutical company headquartered in Brussels with a portfolio of small molecule and antibody based therapies for the treatment of severe immune-mediated diseases and CNS disorders. With over 8500 people in approximately 40 countries, the company generated revenue of € 3.4 billion in 2013. UCB Biopharma SPRL is the R&D subsidiary of UCB which has research and early development scientists based in Belgium (CNS) and UK (Immunology) supporting an innovative pipeline of novel therapeutics. UCB’s core products are treating patients with epilepsy, rheumatoid arthritis and Parkinson’s disease. Researchers at our site in Slough have a strong background in structure-based drug design and are focused on the development of compounds to modulate protein-protein interactions. UCB has a track-record of working with academia and is currently collaborating with world class institutions on multiple targets in CNS, Immunology and other therapeutic areas.
GSK is a research based Pharma company with R&D facilities at multiple locations around the world including the UK, USA, Spain, France, Singapore and China. It conducts fundamental and applied research towards new medicines across a wide range of therapeutic areas including Oncology, Inflammation, Anti- infectives, Respiratiory, Metabolic, Cardiovascular, Neuroscience, Rare Diseases and Diseases of the Developing World.